Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Stefana Bucur has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Extraperitoneal Laparoscopic Approach in Inguinal Hernia—The Ideal Solution?

    by Bogdan Barta, Marina Dumitraș, Ștefana Bucur, Camelia Giuroiu, Raluca Zlotea, Maria-Magdalena Constantin, Victor Mădan, Traian Constantin, Cristina Raluca Iorga

    Background: After more than 20 years since laparoscopy was proposed as a solution for one of the most common surgical pathologies, inguinal hernia, the choice of an intra- or extraperitoneal approach has remained a highly debated topic. Purpose and objectives: This study aimed at analyzing the feasibility of the extraperitoneal approach, by routine for this team/ and answering the question of whether this type of approach can be considered a safe one. Although indications for an intra- or extraperitoneal approach largely overlap, it may also be a matter of surgeon preference in choosing one technique. Methods: The study was retrospective, conducted on a group of 493 patients operated on for inguinal hernia in the clinic, by a single operating team, between January 2012 and March 2022. Results: It was proven that out of the 493 surgeries for inguinal hernia, 95.1% (n = 469) were operated upon by laparoscopic TEP (total extra peritoneal patch plasty approach); 1.62% (n = 8) by laparoscopic TAPP (transabdominal intraperitoneal); and 3.24% (n = 16) by the open, anterior approach (Lichtenstein). There were no intraoperative complications recorded in any of the procedures, while postoperative complications were found in 10.23% of cases (n = 48) in the extraperitoneal approach, and recurrences after the TEP approach were recorded in 0.40% of cases (n = 2). Conclusions: For correctly selected cases, TEP hernia surgery can be considered a safe and reliable approach.


  • ESDR164 - Correlations between etiopathogenic factors and persistence of anti-IL-17A biologic therapies in patients with severe psoriasis vulgaris

    by Stefana Bucur, Maria-Diana Ciurduc, Alexandra-Petruta Savu, Costina-Cristiana Mutu, Elena Serban, Ana-Maria Cuciumita, Rodica Olteanu, Victor Madan, Maria Magdalena Constantin

    In recent years, multiple biologic therapies with various mechanisms of action for the treatment of inflammatory diseases have been developed, in | POSTER

  • ESDR071 - A life-threatening rash induced by an inconspicuous drug

    by Elena Serban, Stefana Bucur, Maria-Diana Ciurduc, Costina-Cristiana Mutu, Alexandra-Petruta Savu, Maria Magdalena Constantin

    Drug-induced rashes are common in the elderly, but some of them can be life-threatening, and for this reason, an appropriate diagnosis and treatm | POSTER

  • ESDR422 - Biologic therapy: the last resort in the treatment of chronic spontaneous urticaria

    by Alexandra-Petruta Savu, Costina-Cristiana Mutu, Elena Serban, Maria-Diana Ciurduc, Ana-Maria Cuciumita, Stefana Bucur, Maria Magdalena Constantin

    Chronic spontaneous urticaria (CSU) is defined by the presence of recurrent hives, associated in over 60% of cases with angioedema, lasting for m | POSTER

  • ESDR067 - Eruptive lichen planus associated with the chronic lymphocytic leukemia: a case report

    by Maria-Diana Ciurduc, Stefana Bucur, Elena Serban, Costina-Cristiana Mutu, Alexandra-Petruta Savu, Maria Magdalena Constantin

    Chronic lymphocytic leukemia (CLL) is a malignant lymphoproliferative disease characterized by the accumulation of immature monoclonal lymphocyte | POSTER

  • ESDR505 - Unusual presentation of classic Kaposi`s sarcoma

    by Costina-Cristiana Mutu, Stefana Bucur, Elena Serban, Maria-Diana Ciurduc, Alexandra-Petruta Savu, Rodica Olteanu, Maria Magdalena Constantin

    Kaposi`s sarcoma is vascular neoplasia, with purplish, infiltrative lesions and the possibility of affecting the viscera or lymph nodes, that can | POSTER

  • ESDR069 - EBA – a dermatological challenge. Clinical case

    by Rodica Olteanu, Ana-Maria Cuciumita, Maria Magdalena Constantin, Stefana Bucur, Victor Madan

    We present the case of a 71-year-old female patient who was admitted to our clinic for the presence of erythematous-petechial and vesiculo-bullou | POSTER

  • Open Access

    Oversight and Management of Women with Psoriasis in Childbearing Age

    by Ștefana Bucur, Alexandra-Petruța Savu, Ana Maria Alexandra Stănescu, Elena-Daniela Șerban, Alin-Codruț Nicolescu, Traian Constantin, Anca Bobircă, Maria-Magdalena Constantin

    Psoriasis is a complex disease with many associated comorbidities, all of which have a negative impact on a patient’s personal, social, and sexual life. There are some unique considerations in the effects of this disease among women. The average age of diagnosis in women with psoriasis is 28 years, and this onset corresponds to the fertile life of women. There is conflicting information about the effects of psoriasis on female fertility. Some studies suggest that this condition’s associated comorbidities, personal behaviors, and reduced ovarian reserve, especially due to chronic inflammation, affect women’s fertility. Another possible reason women with psoriasis are less likely to become pregnant is that their sexual intercourse frequency decreases after the condition’s onset. The available information on the effects of pregnancy on women with psoriasis is limited. According to current evidence, most women will experience an improvement in their skin condition. Studies show that patients with moderate-to-severe psoriasis are more prone to experience pregnancy complications. The management of pregnant and lactating women with psoriasis is also difficult, as the safety profile of commonly used drugs in patients with psoriasis is not entirely known.


  • Retraction
    Open Access

    RETRACTED: Constantin et al. Animal Models in Bladder Cancer. Biomedicines 2021, 9, 1762

    by Traian Constantin, Mihai Păvălean, Ștefana Bucur, Maria Magdalena Constantin, Alin Codruț Nicolescu, Irina Pacu, Victor Mădan

    The journal retracts the article, “Animal Models in Bladder Cancer. Biomedicines 2021, 9, 1762”

  • Retracted
    Open Access

    RETRACTED: Animal Models in Bladder Cancer

    by Traian Constantin, Mihai Păvălean, Ștefana Bucur, Maria Magdalena Constantin, Alin Codruț Nicolescu, Irina Pacu, Victor Mădan

    Background: Bladder cancer (urothelial cancer of the bladder) is the most common malignancy affecting the urinary system with an increasing incidence and mortality. Mouse models of bladder cancer should possess a high value of reproducibility, predictability, and translatability to allow mechanistic, chemo-preventive, and therapeutic studies that can be furthered into human clinical trials. Objectives: To provide an overview and resources on the origin, molecular and pathological characteristics of commonly used animal models in bladder cancer. Methods: A PubMed and Web of Science search was performed for relevant articles published between 1980 and 2021 using words such as: “bladder” and/or “urothelial carcinoma” and animal models. Animal models of bladder cancer can be categorized as autochthonous (spontaneous) and non-autochthonous (transplantable). The first are either chemically induced models or genetically engineered models. The transplantable models can be further subclassified as syngeneic (murine bladder cancer cells implanted into immunocompetent or transgenic mice) and xenografts (human bladder cancer cells implanted into immune-deficient mice). These models can be further divided—based on the site of the tumor—as orthotopic (tumor growth occurs within the bladder) and heterotopic (tumor growth occurs outside of the bladder).